Verisante Technology Inc. (VRSEF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -30.42 Thousand CAD | 64.53% |
| 2022 | -85.78 Thousand CAD | 37.6% |
| 2021 | -137.47 Thousand CAD | 0.0% |
| 2020 | - CAD | -100.0% |
| 2019 | 56.98 Thousand CAD | 0.0% |
| 2018 | 56.98 Thousand CAD | -92.14% |
| 2017 | 724.5 Thousand CAD | 134.35% |
| 2016 | 309.15 Thousand CAD | 103.33% |
| 2015 | 152.04 Thousand CAD | 144.77% |
| 2014 | -339.61 Thousand CAD | 25.43% |
| 2013 | -455.42 Thousand CAD | 26.64% |
| 2012 | -620.76 Thousand CAD | 78.12% |
| 2011 | -2.83 Million CAD | -527.37% |
| 2010 | -452.27 Thousand CAD | 48.17% |
| 2009 | -872.56 Thousand CAD | -802.93% |
| 2008 | -96.63 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -6789.00 CAD | 77.58% |
| 2024 Q1 | -30.28 Thousand CAD | 0.46% |
| 2023 Q4 | -30.42 Thousand CAD | 24.42% |
| 2023 Q1 | -66.19 Thousand CAD | 22.83% |
| 2023 Q3 | -40.25 Thousand CAD | 2.27% |
| 2023 FY | -30.42 Thousand CAD | 64.53% |
| 2023 Q2 | -41.18 Thousand CAD | 37.78% |
| 2022 Q2 | -12.77 Thousand CAD | 11.86% |
| 2022 Q1 | -14.49 Thousand CAD | 89.46% |
| 2022 Q3 | -101.44 Thousand CAD | -694.13% |
| 2022 FY | -85.78 Thousand CAD | 37.6% |
| 2022 Q4 | -85.78 Thousand CAD | 15.44% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 FY | -137.47 Thousand CAD | 0.0% |
| 2021 Q4 | -137.47 Thousand CAD | 0.0% |
| 2020 FY | - CAD | -100.0% |
| 2019 FY | 56.98 Thousand CAD | 0.0% |
| 2018 FY | 56.98 Thousand CAD | -92.14% |
| 2017 Q4 | 724.5 Thousand CAD | 10.19% |
| 2017 Q1 | 586.81 Thousand CAD | 89.82% |
| 2017 Q2 | 606.6 Thousand CAD | 3.37% |
| 2017 FY | 724.5 Thousand CAD | 134.35% |
| 2017 Q3 | 657.49 Thousand CAD | 8.39% |
| 2016 Q1 | 232.99 Thousand CAD | 53.24% |
| 2016 Q4 | 309.15 Thousand CAD | 6.13% |
| 2016 Q3 | 291.29 Thousand CAD | -2.78% |
| 2016 Q2 | 299.63 Thousand CAD | 28.6% |
| 2016 FY | 309.15 Thousand CAD | 103.33% |
| 2015 FY | 152.04 Thousand CAD | 144.77% |
| 2015 Q1 | -8537.00 CAD | 97.49% |
| 2015 Q2 | 54.4 Thousand CAD | 737.26% |
| 2015 Q3 | 139.53 Thousand CAD | 156.48% |
| 2015 Q4 | 152.04 Thousand CAD | 8.97% |
| 2014 Q1 | -159.44 Thousand CAD | 64.99% |
| 2014 FY | -339.61 Thousand CAD | 25.43% |
| 2014 Q3 | -38.34 Thousand CAD | 85.37% |
| 2014 Q4 | -339.61 Thousand CAD | -785.67% |
| 2014 Q2 | -262.04 Thousand CAD | -64.34% |
| 2013 Q3 | -288.24 Thousand CAD | 71.71% |
| 2013 FY | -455.42 Thousand CAD | 26.64% |
| 2013 Q4 | -455.42 Thousand CAD | -58.0% |
| 2013 Q2 | -1.01 Million CAD | 14.24% |
| 2013 Q1 | -1.18 Million CAD | -91.39% |
| 2012 Q4 | -620.76 Thousand CAD | 12.05% |
| 2012 FY | -620.76 Thousand CAD | 78.12% |
| 2012 Q1 | -1.85 Million CAD | 34.59% |
| 2012 Q2 | -487.21 Thousand CAD | 73.75% |
| 2012 Q3 | -705.81 Thousand CAD | -44.87% |
| 2011 FY | -2.83 Million CAD | -527.37% |
| 2011 Q1 | -1.01 Million CAD | -123.48% |
| 2011 Q2 | -1.93 Million CAD | -91.3% |
| 2011 Q3 | -3.11 Million CAD | -61.34% |
| 2011 Q4 | -2.83 Million CAD | 9.05% |
| 2010 Q1 | -615.41 Thousand CAD | 29.47% |
| 2010 FY | -452.27 Thousand CAD | 48.17% |
| 2010 Q4 | -452.27 Thousand CAD | 20.33% |
| 2010 Q3 | -567.69 Thousand CAD | -127.79% |
| 2010 Q2 | -249.21 Thousand CAD | 59.5% |
| 2009 Q4 | -872.56 Thousand CAD | -1150.05% |
| 2009 Q3 | -69.8 Thousand CAD | 0.0% |
| 2009 FY | -872.56 Thousand CAD | -802.93% |
| 2008 FY | -96.63 Thousand CAD | 0.0% |
| 2008 Q4 | -96.63 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | -26.23 Million USD | 99.884% |
| Manhattan Scientifics, Inc. | -7000.00 USD | -334.643% |
| Össur hf. | 395.08 Million USD | 100.008% |
| QHSLab, Inc. | 1.72 Million USD | 101.759% |
| Wellstar International, Inc. | 51.36 Million USD | 100.059% |
| Össur hf. | 395.08 Million USD | 100.008% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| Escalon Medical Corp. | 315.68 Thousand USD | 109.638% |
| Aurora Spine Corporation | 1.9 Million USD | 101.595% |
| BrainsWay Ltd. | -10.32 Million USD | 99.705% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| BioElectronics Corporation | 14.82 Million USD | 100.205% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 100.168% |
| Vivos Inc. | -1.59 Million USD | 98.089% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 106.243% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 94.376% |
| Zecotek Photonics Inc. | 2.76 Million USD | 101.101% |
| Avitar, Inc. | 5.17 Million USD | 100.588% |
| Nanomix Corporation | 11.38 Million USD | 100.267% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 99.341% |
| Theraclion SA | -5.86 Million EUR | 99.481% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Positron Corporation | 1.68 Million USD | 101.804% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 101.889% |
| Lombard Medical, Inc. | 11.49 Million USD | 100.265% |
| ALR Technologies Inc. | 19.14 Million USD | 100.159% |
| Stratec SE | 119.12 Million USD | 100.026% |
| Vycor Medical, Inc. | 1.05 Million USD | 102.889% |
| Heart Tronics, Inc. | 54.99 Thousand USD | 155.323% |
| MicroPort Scientific Corporation | 673.58 Million USD | 100.005% |
| VMS Rehab Systems, Inc. | 133.52 USD | 22886.848% |
| NewCardio, Inc. | 2.41 Million USD | 101.26% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 102.074% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 104.822% |
| Odyssey Group International, Inc. | 2.1 Million USD | 101.443% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 104.752% |
| Wellness Center USA, Inc. | 3.98 Million USD | 100.763% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 100.101% |
| IR-Med Inc. | -606 Thousand USD | 94.979% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 99.779% |
| Polarean Imaging plc | -5.94 Million USD | 99.488% |
| United American Healthcare Corporation | -9.32 Million USD | 99.674% |
| ECGI Holdings, Inc. | 3.17 Million USD | 100.959% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | 132.647% |
| Capital Group Holdings, Inc. | -3508.00 USD | -767.303% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 111.585% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | 114.046% |
| Urologix, Inc. | 4.61 Million USD | 100.659% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 100.723% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 100.913% |
| SS Innovations International, Inc. | 1.18 Million USD | 102.567% |
| Qualis Innovations, Inc. | 6671.00 USD | 556.079% |
| Smith & Nephew plc | 2.77 Billion USD | 100.001% |
| NIOX Group Plc | -23.93 Million USD | 99.873% |
| Fuse Medical, Inc. | 1.75 Million USD | 101.733% |
| Broncus Holding Corporation | -81.42 Million USD | 99.963% |
| Brain Scientific Inc. | 2.11 Million USD | 101.438% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 100.134% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | 176.914% |